A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
Biperiden has been studied across 16 research domains including 🧠 Neuroprotection, 🌤️ Mood & Depression, 🧠 Focus & Attention, 😴 Sleep, 🧠 Memory. The primary research focus is 🧠 Neuroprotection with 20% of studies addressing this area.
This evidence profile for Biperiden is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.